SUMITOMO CORP
SUMITOMO CORP
Share · JP3404600003 · 860364 (XTKS)
Overview Financial Indicators
22,41 EUR
-3,62 % -0,84 EUR
Tokyo · Current prices and charts at MoneyPeak
06.06.2025 19:22

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 3,01 % - - - - -

Invested Funds

The following funds have invested in: SUMITOMO CORP invested:

Fund
iShares Dow Jones Asia Pacific Select Dividend 50 UCITS ETF (DE)
Vol. in million
4.377,06
Percentage (%)
1,80 %
Fund
iShares MSCI Japan ESG Screened UCITS ETF USD (Acc)
Vol. in million
3.299,90
Percentage (%)
0,41 %
Fund
iShares MSCI Japan ESG Screened UCITS ETF USD (Dist)
Vol. in million
491,42
Percentage (%)
0,41 %
Fund
iShares MSCI Japan CHF Hedged UCITS ETF (Acc)
Vol. in million
901,58
Percentage (%)
0,40 %
Fund
iShares MSCI Japan USD Hedged UCITS ETF
Vol. in million
1.602,03
Percentage (%)
0,40 %

Company Data

Name SUMITOMO CORP
Website https://www.sumitomocorp.com
Primary Exchange XTKS Tokyo
WKN 860364
ISIN JP3404600003
Asset Class Share
Currency EUR

Ticker Symbols

Name Symbol
Frankfurt SUMA.F

More Shares

Investors who SUMITOMO CORP hold also have the following shares in their portfolio:
CANOPY GROWTH
CANOPY GROWTH Share
CLAVIS SECURITIES PLC CLASS M2A NTS 15/12/39
CLAVIS SECURITIES PLC CLASS M2A NTS 15/12/39 Bond
GLOBAL PAYMENTS INC
GLOBAL PAYMENTS INC Share
ISHARES MSCI WORLD (ACC)
ISHARES MSCI WORLD (ACC) ETF
META PLATFORMS INC
META PLATFORMS INC Share
MITSUI + CO
MITSUI + CO Share
NORDLB 3 PH.BD. 12/19
NORDLB 3 PH.BD. 12/19 Bond
REALTY INCOME CORP
REALTY INCOME CORP Share
STELLANTIS NV     EO -,01
STELLANTIS NV EO -,01 Share
SYNBIOTIC SE
SYNBIOTIC SE Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025